Related Experiment Video
Updated: Aug 5, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
L-arginine increases exhaled nitric oxide in normal human subjects
S A Kharitonov1, G Lubec, B Lubec
1Department of Thoracic Medicine, National Heart and Lung Institute, London, U.K.
Oral L-arginine supplementation significantly increases exhaled nitric oxide levels in healthy individuals. This finding suggests L-arginine may enhance endogenous nitric oxide production, potentially benefiting conditions with nitric oxide deficiency.
Area of Science:
- Physiology
- Biochemistry
- Respiratory Medicine
Background:
- Endogenous nitric oxide (NO) is vital for physiological functions.
- Nitric oxide synthase (NOS) synthesizes NO from L-arginine.
- Exhaled nitric oxide (eNO) reflects NO production in the respiratory tract.
Purpose of the Study:
- To investigate the effect of oral L-arginine on eNO concentrations.
- To determine if L-arginine supplementation increases endogenous NO formation.
Main Methods:
- Twenty-three healthy individuals received varying doses of oral L-arginine (0.05, 0.1, 0.2 g/kg) or placebo.
- Exhaled nitric oxide levels were measured.
- Plasma L-arginine and nitrate concentrations were analyzed.
Main Results:
- L-arginine significantly increased eNO at doses of 0.1 and 0.2 g/kg.
- Peak eNO levels occurred 2 hours post-administration.
- Increased plasma L-arginine and nitrate levels were observed.
Conclusions:
- Supplementing with L-arginine enhances endogenous nitric oxide production.
- Increased substrate availability for NOS boosts NO formation.
- This approach may hold therapeutic potential for diseases characterized by impaired NO synthesis.
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
Factors Affecting Respiration
Nitric Oxide Signaling Pathway
COPD: Management Using Bronchodilators and Corticosteroids
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...

